DashboardForm 483sForm 483 Details

Regeneron Pharmaceuticals, Inc. Form 483 Details

Form 483
View FDA's record for this firm
Source: Third-party index, not matched to FDAThis record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3015581066.

Regeneron Pharmaceuticals, Inc.

New York
Issue DateJanuary 16, 2026
FEI Number3015581066
CountryUnited States
Status
No Warning Letter
Establishment Type
Drug Product Manufacturer
Regeneron Pharmaceuticals, Inc. FDA Form 483, New York, January 16, 2026